Diridavumab Biosimilar – Anti-hemagglutinin HA2 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameDiridavumab Biosimilar - Anti-hemagglutinin HA2 mAb - Research Grade
SourceCAS 1393659-46-5
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsDiridavumab,CR-6261,CR6261,hemagglutinin HA2,anti-hemagglutinin HA2
ReferencePX-TA1349
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-lambda
ClonalityMonoclonal Antibody

Description of Diridavumab Biosimilar - Anti-hemagglutinin HA2 mAb - Research Grade

General information on Anti-influenza A virus hemagglutinin HA2 subunit from various strains[Influenza A virus] (Diridavumab) Monoclonal Antibody

Diridavumab monoclonal antibody targets A hemagglutinin in a broad range of the influenza virus.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Diridavumab Biosimilar – Anti-hemagglutinin HA2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Hemagglutinin(HA) Japan
Antigen

Hemagglutinin(HA) Japan

PX-P4417 210€
Stable Isotope Labelled Diridavumab Biosimilar – Anti-hemagglutinin HA2 mAb – Research Grade
SIL

Stable Isotope Labelled Diridavumab Biosimilar – Anti-hemagglutinin HA2 mAb – Research Grade

PX-TA1349-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products